Blog
RSS FeedPosted by Michael Wonder on 20 May 2020
Europe falls behind U.S. in funding coronavirus vaccine and securing access
19 May 2020 - U.S. was faster in shouldering drug companies’ costs to develop and manufacture vaccine candidates, putting the bloc ...
Posted by Michael Wonder on 19 May 2020
Top pharma official rejects idea of free COVID-19 vaccine for all
18 May 2020 - A leading representative of the pharmaceutical industry has downplayed the idea of a vaccine against the ...
Posted by Michael Wonder on 14 May 2020
Coronavirus vaccine could be ready in a year: EU medicine agency
14 May 2020 - A vaccine to counter the new coronavirus could be approved in about a year in an ...
Posted by Michael Wonder on 05 May 2020
World leaders donate to COVID-19 vaccine funding drive
5 May 2020 - Experts says $20 billion needed to vaccinate global population. ...
Posted by Michael Wonder on 04 May 2020
COVID-19: how EMA fast-tracks development support and approval of medicines and vaccines
4 May 2020 - As researchers race to develop vaccines and therapeutics against COVID-19, EMA has published an overview of how ...
Posted by Michael Wonder on 04 May 2020
AstraZeneca to make Oxford vaccine as COVID-19 race heats up
30 April 2020 - AstraZeneca agreed to make an experimental coronavirus vaccine developed by Oxford University researchers as the race ...
Posted by Michael Wonder on 04 May 2020
Boris Johnson’s global vaccine push as he revealed the birth of his son helped him fight COVID-19
4 May 2020 - Boris Johnson will hold a virtual meeting online, and demand countries around the world pull together ...
Posted by Michael Wonder on 23 Apr 2020
The race to find a COVID-19 vaccine
23 April 2020 - The sum of £42.5 million is a lot to pay for a small sliver of protein. ...
Posted by Michael Wonder on 21 Apr 2020
Human trials to begin on COVID-19 vaccine by Thursday
21 April 2020 - A million doses of their experimental coronavirus vaccine could be ready as early as September, Oxford scientists ...
Posted by Michael Wonder on 16 Apr 2020
Meeting highlights from ICMRA global regulatory workshop on COVID-19 observational studies and real world data
16 April 2020 - Observational studies of data generated in clinical practice in the context of COVID-19 can contribute to the ...
Posted by Michael Wonder on 15 Apr 2020
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
14 April 2020 - Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to ...
Posted by Michael Wonder on 23 Mar 2020
FDA and EMA collaborate to facilitate SARS-CoV-2 vaccine development
23 March 2020 - Vaccines offer a way to build immunity to a disease-causing microorganism before one has ever been exposed ...
Posted by Michael Wonder on 18 Mar 2020
First regulatory workshop on COVID-19 facilitates global collaboration on vaccine development
18 March 2020 - Today, the first global regulatory workshop on COVID-19, was convened under the umbrella of the International Coalition ...
Posted by Michael Wonder on 14 Mar 2020
COVID-19: developers of medicines or vaccines to benefit from free scientific advice
13 March 2020 - EMA provides full fee waivers for scientific advice applications from developers of potential therapeutics (to treat ...
Posted by Michael Wonder on 05 Feb 2020
EMA to support development of vaccines and treatments for novel coronavirus
4 February 2020 - To contribute to the global response to the outbreak of the novel coronavirus (2019-nCoV) infections, EMA ...